메뉴 건너뛰기




Volumn 9, Issue 4, 2007, Pages 289-297

New anticoagulant options ST-elevation myocardial infarction and unstable angina pectoris/non-ST-elevation myocardial infarction

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ARGATROBAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; PROTAMINE SULFATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RETEPLASE; STREPTOKINASE; TENECTEPLASE; THROMBIN; THROMBIN INHIBITOR;

EID: 34447514185     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02938377     Document Type: Review
Times cited : (3)

References (42)
  • 1
    • 10944239058 scopus 로고    scopus 로고
    • ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1999 guideline for the management of patients with acute myocardial infarction)
    • Antman EM, Anbe DT, Armstrong PW, et al.: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1999 guideline for the management of patients with acute myocardial infarction). Circulation 2004, 110:e82-e292.
    • (2004) Circulation , vol.110
    • Antman, E.M.1    Anbe, D.T.2    Armstrong, P.W.3
  • 2
    • 38049172418 scopus 로고    scopus 로고
    • focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association task force on practice guidelines
    • June, in press
    • Antman EM, Hand M, Armstrong PW, et al.: June 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2007, in press.
    • (2007) Circulation
    • Antman, E.M.1    Hand, M.2    Armstrong, P.W.3
  • 3
    • 0037232464 scopus 로고    scopus 로고
    • Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European Society of Cardiology
    • Van de Werf F, Ardissino D, Betriu A, et al.: Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2003, 24:28-66.
    • (2003) Eur Heart J , vol.24 , pp. 28-66
    • Van de Werf, F.1    Ardissino, D.2    Betriu, A.3
  • 4
    • 0036788546 scopus 로고    scopus 로고
    • ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Summary article
    • A report of the American College of Cardiology/American Heart Association task force on practice guidelines Committee on the management of patients with unstable angina
    • Braunwald E, Antman EM, Beasley JW, et al.: ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the management of patients with unstable angina). Circulation 2002, 106:1893-1900.
    • (2002) Circulation , vol.106 , pp. 1893-1900
    • Braunwald, E.1    Antman, E.M.2    Beasley, J.W.3
  • 5
    • 0036892858 scopus 로고    scopus 로고
    • Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
    • Bertrand ME, Simoons ML, Fox KA, et al.: Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002, 23:1809-1840.
    • (2002) Eur Heart J , vol.23 , pp. 1809-1840
    • Bertrand, M.E.1    Simoons, M.L.2    Fox, K.A.3
  • 6
    • 34447555473 scopus 로고    scopus 로고
    • Konkle BA, Schafer AI: Hemostasis, thrombosis, fibrinolysis, and cardiovascular disease. In Braunwald's Heart Disease, 2, edn 7. Edited by Braunwald E, Zipes DP, Libby P, Bonow RO. Philadelphia: WB Saunders; 2005:2067-2092.
    • Konkle BA, Schafer AI: Hemostasis, thrombosis, fibrinolysis, and cardiovascular disease. In Braunwald's Heart Disease, vol 2, edn 7. Edited by Braunwald E, Zipes DP, Libby P, Bonow RO. Philadelphia: WB Saunders; 2005:2067-2092.
  • 7
    • 2542581490 scopus 로고    scopus 로고
    • Bivalirudin: An anticoagulant option for percutaneous coronary intervention
    • Bates ER: Bivalirudin: an anticoagulant option for percutaneous coronary intervention. Expert Rev Cardiovasc Ther 2004:153-162.
    • (2004) Expert Rev Cardiovasc Ther , pp. 153-162
    • Bates, E.R.1
  • 8
    • 0036660207 scopus 로고    scopus 로고
    • Thrombin functions during tissue factor-induced blood coagulation
    • Brummel KE, Paradis SG, Butenas S, Mann KG: Thrombin functions during tissue factor-induced blood coagulation. Blood 2002, 100:148-152.
    • (2002) Blood , vol.100 , pp. 148-152
    • Brummel, K.E.1    Paradis, S.G.2    Butenas, S.3    Mann, K.G.4
  • 9
    • 0034971291 scopus 로고    scopus 로고
    • A cell-based model of hemostasis
    • Hoffman M, Monroe DM: A cell-based model of hemostasis. Thromb Haemost 2001, 85, 958-965.
    • (2001) Thromb Haemost , vol.85 , pp. 958-965
    • Hoffman, M.1    Monroe, D.M.2
  • 11
    • 0034648757 scopus 로고    scopus 로고
    • Coughlin SR: Thrombin signaling and protease-activated receptors. Nature 2000, 407:2S8-264.
    • Coughlin SR: Thrombin signaling and protease-activated receptors. Nature 2000, 407:2S8-264.
  • 12
    • 0027240597 scopus 로고
    • An international randomized trial comparing four thrombolytic strategies for acute myocardial infafction
    • The GUSTO Investigators
    • The GUSTO Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infafction. N Engl J Med 1993, 329:673-682.
    • (1993) N Engl J Med , vol.329 , pp. 673-682
  • 13
    • 0030893793 scopus 로고    scopus 로고
    • Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction
    • Collins R, Peto R, Baigent C, Sleight P: Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med 1997, 336:847-860.
    • (1997) N Engl J Med , vol.336 , pp. 847-860
    • Collins, R.1    Peto, R.2    Baigent, C.3    Sleight, P.4
  • 14
    • 0037438875 scopus 로고    scopus 로고
    • Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention
    • Wong GC, Giugliano RP, Antman EM: Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention. JAMA 2003, 289:331-342.
    • (2003) JAMA , vol.289 , pp. 331-342
    • Wong, G.C.1    Giugliano, R.P.2    Antman, E.M.3
  • 15
    • 0035949117 scopus 로고    scopus 로고
    • Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction
    • ASSENT-3 Investigators
    • ASSENT-3 Investigators: Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001, 358:605-613.
    • (2001) Lancet , vol.358 , pp. 605-613
  • 16
    • 0038447936 scopus 로고    scopus 로고
    • Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 plus randomized trial in acute myocardial infarction
    • Wallentin L, Goldstein P, Armstrong PW, ct al.: Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 plus randomized trial in acute myocardial infarction. Circulation 2003, 108:135-142.
    • (2003) Circulation , vol.108 , pp. 135-142
    • Wallentin, L.1    Goldstein, P.2    Armstrong, P.W.3    ct al4
  • 17
    • 33645515458 scopus 로고    scopus 로고
    • Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction
    • Antman EM, Morrow DA, McCabe CH, et al.: Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 2006, 354:1477-1488.
    • (2006) N Engl J Med , vol.354 , pp. 1477-1488
    • Antman, E.M.1    Morrow, D.A.2    McCabe, C.H.3
  • 18
    • 34249824588 scopus 로고    scopus 로고
    • Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin following fibrinolytic therapy for ST-elevation myocardial infarction in the EXTRACT-TIMI 25 trial
    • in press
    • Gibson CM, Murphy SA, Montalescot G, et al.: Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin following fibrinolytic therapy for ST-elevation myocardial infarction in the EXTRACT-TIMI 25 trial. J Am Coll Cardiol 2007, in press.
    • (2007) J Am Coll Cardiol
    • Gibson, C.M.1    Murphy, S.A.2    Montalescot, G.3
  • 19
    • 33645497961 scopus 로고    scopus 로고
    • Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction. The OASIS-6 randomized trial
    • Yusuf S, Mehta SR, Chrolavicius S, et al.: Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction. The OASIS-6 randomized trial. JAMA 2006, 295:1519-1530.
    • (2006) JAMA , vol.295 , pp. 1519-1530
    • Yusuf, S.1    Mehta, S.R.2    Chrolavicius, S.3
  • 20
    • 0030771823 scopus 로고    scopus 로고
    • Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) trial investigators
    • White HD, Aylward PE, Frey MJ, et al.: Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) trial investigators. Circulation 1997, 96:2155-2161.
    • (1997) Circulation , vol.96 , pp. 2155-2161
    • White, H.D.1    Aylward, P.E.2    Frey, M.J.3
  • 21
    • 0035651983 scopus 로고    scopus 로고
    • Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: The HERO-2 randomised trial
    • White H: Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet 2001, 358:1855-1863.
    • (2001) Lancet , vol.358 , pp. 1855-1863
    • White, H.1
  • 22
    • 0034600424 scopus 로고    scopus 로고
    • Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: A meta-analysis
    • Eikelboom JW, Anand SS, Malmberg K, et al.: Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet 2000, 355:1936-1942.
    • (2000) Lancet , vol.355 , pp. 1936-1942
    • Eikelboom, J.W.1    Anand, S.S.2    Malmberg, K.3
  • 23
    • 8544279582 scopus 로고    scopus 로고
    • A comparison of low-molecular weight heparin with unfractionated heparin for unstable coronary artery disease
    • Cohen M, Demers C, Gurfinkel EP, et al.: A comparison of low-molecular weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997, 337:447-452.
    • (1997) N Engl J Med , vol.337 , pp. 447-452
    • Cohen, M.1    Demers, C.2    Gurfinkel, E.P.3
  • 24
    • 0032870952 scopus 로고    scopus 로고
    • Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: Results of the TIMI 11B trial
    • Antman EA, McCabe CH, Gurfinkel EP, et al.: Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: results of the TIMI 11B trial. Circulation 1999, 100:1593-1601.
    • (1999) Circulation , vol.100 , pp. 1593-1601
    • Antman, E.A.1    McCabe, C.H.2    Gurfinkel, E.P.3
  • 25
    • 0032855125 scopus 로고    scopus 로고
    • Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis
    • Antman EM, Cohen M, Radley D, et al.: Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. Circulation 1999, 100:1602-1608.
    • (1999) Circulation , vol.100 , pp. 1602-1608
    • Antman, E.M.1    Cohen, M.2    Radley, D.3
  • 26
    • 0036735080 scopus 로고    scopus 로고
    • Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study
    • Cohen M, Theroux P, Borzak S, et al.: Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. Am Heart j 2002, 144:470-477.
    • (2002) Am Heart j , vol.144 , pp. 470-477
    • Cohen, M.1    Theroux, P.2    Borzak, S.3
  • 27
    • 0037458122 scopus 로고    scopus 로고
    • Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide
    • Goodman SG, Fitchett D, Armstrong PW, et al.: Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Circulation 2003, 107:238-244.
    • (2003) Circulation , vol.107 , pp. 238-244
    • Goodman, S.G.1    Fitchett, D.2    Armstrong, P.W.3
  • 28
    • 3042820414 scopus 로고    scopus 로고
    • Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial
    • Blazing MA, de Lemos JA, White HD, et al.: Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. JAMA 2004, 292:55-64.
    • (2004) JAMA , vol.292 , pp. 55-64
    • Blazing, M.A.1    de Lemos, J.A.2    White, H.D.3
  • 29
    • 3042782723 scopus 로고    scopus 로고
    • Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial
    • The SYNERGY Trial Investigators
    • The SYNERGY Trial Investigators: Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004, 292:45-54.
    • (2004) JAMA , vol.292 , pp. 45-54
  • 30
    • 3042784252 scopus 로고    scopus 로고
    • Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes. A systemic overview
    • Petersen JL, Mahaffey KW, Hasselblad V, et al.: Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes. A systemic overview. JAMA 2004, 292:89-96.
    • (2004) JAMA , vol.292 , pp. 89-96
    • Petersen, J.L.1    Mahaffey, K.W.2    Hasselblad, V.3
  • 31
    • 33645498094 scopus 로고    scopus 로고
    • Comparison of fondaparinux and enoxaparin in acute coronary syndromes
    • for the OASIS-5 Investigators
    • Yusuf S, Mehta SR, Chrolavicius S, et al.: for the OASIS-5 Investigators: Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006, 354:1464-1476.
    • (2006) N Engl J Med , vol.354 , pp. 1464-1476
    • Yusuf, S.1    Mehta, S.R.2    Chrolavicius, S.3
  • 32
    • 0036482419 scopus 로고    scopus 로고
    • Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: Observations from the TIMI 8 trial
    • Antman EM, McCabe CH, Braunwald E: Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. Am Heart J 2002, 143:229-234.
    • (2002) Am Heart J , vol.143 , pp. 229-234
    • Antman, E.M.1    McCabe, C.H.2    Braunwald, E.3
  • 33
    • 0037453968 scopus 로고    scopus 로고
    • Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention. REPLACE-2 randomized trial
    • for the REPLACE-2 Investigators
    • Lincoff AM, Bittl JA, Harrington RA, et al.: for the REPLACE-2 Investigators: Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention. REPLACE-2 randomized trial. JAMA 2003:289:853-863.
    • (2003) JAMA , vol.289 , pp. 853-863
    • Lincoff, A.M.1    Bittl, J.A.2    Harrington, R.A.3
  • 34
    • 33745675382 scopus 로고    scopus 로고
    • Outcomes of patients with acute coronary syndromes who are treated with bivalidurin during percutaneous coronary intervention: An analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial
    • Rajagopal V, Lincoff AM, Cohen DJ, et al.: Outcomes of patients with acute coronary syndromes who are treated with bivalidurin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial. Am Heart J 2006, 152:149-154.
    • (2006) Am Heart J , vol.152 , pp. 149-154
    • Rajagopal, V.1    Lincoff, A.M.2    Cohen, D.J.3
  • 35
    • 33744975578 scopus 로고    scopus 로고
    • A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: The PROTECT-TIMI 30 trial
    • Gibson CM, Morrow DA, Murphy SA, et al.: A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI 30 trial. J Am Coll Cardiol 2006, 47.2364-2373.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 2364-2373
    • Gibson, C.M.1    Morrow, D.A.2    Murphy, S.A.3
  • 36
    • 33751221316 scopus 로고    scopus 로고
    • Bivalirudin for patients with acute coronary syndromes
    • for the ACUITY Investigators
    • Stone GW, McLaurin BT, Cox DA, et al.: for the ACUITY Investigators: Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006, 355:2203-2216.
    • (2006) N Engl J Med , vol.355 , pp. 2203-2216
    • Stone, G.W.1    McLaurin, B.T.2    Cox, D.A.3
  • 37
    • 33947187284 scopus 로고    scopus 로고
    • Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial
    • Stone GW, White HD, Ohman EM, et al.: Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet 2007, 369:907-919.
    • (2007) Lancet , vol.369 , pp. 907-919
    • Stone, G.W.1    White, H.D.2    Ohman, E.M.3
  • 38
    • 0029938993 scopus 로고    scopus 로고
    • Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: Results from the GUSTO-1 trial
    • Granger CB, Hirsch J, Califf RM, et al.: Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-1 trial. Circulation 1996, 93:870-878.
    • (1996) Circulation , vol.93 , pp. 870-878
    • Granger, C.B.1    Hirsch, J.2    Califf, R.M.3
  • 39
    • 27144475755 scopus 로고    scopus 로고
    • Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes
    • Rao SV, O'Grady K, Pieper KS, et al.: Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 2005, 96:1200-1206.
    • (2005) Am J Cardiol , vol.96 , pp. 1200-1206
    • Rao, S.V.1    O'Grady, K.2    Pieper, K.S.3
  • 40
    • 29544437848 scopus 로고    scopus 로고
    • Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-elevation acute coronary syndromes
    • Alexander KP, Chen AY, Roe MT, et al.: Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-elevation acute coronary syndromes. JAMA 2006, 295:3108-3116.
    • (2006) JAMA , vol.295 , pp. 3108-3116
    • Alexander, K.P.1    Chen, A.Y.2    Roe, M.T.3
  • 41
    • 4644350897 scopus 로고    scopus 로고
    • Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes
    • Rao SV, Jollis JG, Harrington RA, et al.: Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004, 292:1555-1562.
    • (2004) JAMA , vol.292 , pp. 1555-1562
    • Rao, S.V.1    Jollis, J.G.2    Harrington, R.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.